Comparison of the relative sensitivity of human lymphocytes and mouse splenocytes to two spindle poisons

G Steiblen1, T Orsière, C Pallen

  • 1Bayer Cropscience, Centre de Recherche de Sophia Antipolis, BP 153, France. guy.steiblen@bayercropscience.com

Mutation Research
|November 29, 2005
PubMed

Insights

Mouse splenocytes offer a viable alternative to human lymphocytes for identifying aneugenic compounds. This study harmonized protocols and found comparable genotoxic responses, with mouse cells showing higher sensitivity to paclitaxel.

Area of Science:

  • Toxicology
  • Genetics
  • Cell Biology

Background:

  • Aneugenic compounds cause genotoxicity indirectly and may have activity thresholds.
  • Determining these thresholds is crucial for assessing human exposure risks.
  • Existing in vitro micronucleus assays primarily use human lymphocytes, limiting comparative data with in vivo mouse models.

Purpose of the Study:

  • To evaluate mouse splenocytes as an alternative to human lymphocytes for identifying aneugenic compounds.
  • To harmonize in vitro protocols for direct comparison between human and mouse cell models.
  • To compare the sensitivity of mouse and human cell models to known aneugens.

Main Methods:

  • Harmonized in vitro micronucleus assay protocols for human lymphocytes and mouse splenocytes.
  • Used specific mitogens (PHA for human, concanavalin A for mouse) and cytochalasin B to standardize cell proliferation and binucleation.
  • Exposed both cell types to nocodazole and paclitaxel to compare genotoxic responses.

Main Results:

  • Achieved reproducible cytotoxic and genotoxic responses in both human and mouse cell models.
  • Mouse splenocytes demonstrated higher sensitivity to paclitaxel compared to human lymphocytes.
  • Both cell types exhibited similar sensitivity to nocodazole.

Conclusions:

  • Mouse splenocytes are a suitable alternative to human lymphocytes for in vitro genotoxicity testing of aneugens.
  • The harmonized protocols allow for valid comparisons of in vitro and in vivo aneugen activity thresholds.
  • This model facilitates a better understanding of aneugen risk assessment.

Related Concept Videos